It has also been reported that the up-regulation of RCN2 can activate the MYC signal and regulate the activation of the EGFR-ERK pathway to promote the occurrence of hepatocellular carcinoma (HCC)43. Here, RCN2 is linked to hepatocellular carcinoma.